Opdivo Qvantig

News

BMS beats MSD to the US subcutaneous PD-1 inhibitor market after Opdivo Qvantiq is cleared across nearly all the indications of the IV form.

Patients

James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.